Investigación

Leucemia y hemopatías pediátricas

Buscador de publicaciones

Publicaciones

  • Ahlgren, L, Pilheden, M, Sturesson, H, Song, GC, Walsh, MP, Yang, MJ, Maillard, M, Zhao, HB, Cheng, ZS, Singh, V, Castor, A, Pronk, CJ, Marquart, HV, Lausen, B, Schneider, P, Barbany, G, Tamm, KP, Abrahamsson, J, Lohi, O, Fogelstrand, L, Menendez, P, Pieters, R, Zhang, JH, Lindkvist-Petersson, K, Yang, JJ, Gruber, TA, Stam, RW, Ma, J and Hagström-Andersson, AK.

    The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia

    Nature Communications . 16(1): . Nº de citas: 1

    [doi:10.1038/s41467-025-64190-8]

  • Ghanjati, F, Heck, A, Lebrecht, D, Nöllke, P, Andresen, F, Rotari, N, Schoof, M, Schönung, M, Lipka, DB, Dworzak, M, De Moerloose, B, Sukova, M, Hasle, H, Jahnukainen, K, Malone, A, Masetti, R, Buechner, J, Ussowicz, M, Català-Temprano A, Turkiewicz, D, de Haas, V, Schmugge, M, Erlacher, M, Niemeyer, CM and Flotho, C.

    Epigenetic risk stratification in juvenile myelomonocytic leukemia by targeted methylation analysis of the BMP4 locus

    Clinical Epigenetics . 17(1): .

    [doi:10.1186/s13148-025-01983-0]

  • Fuentes P, García-Peydró M, Alcain J, Mosquera M, Cela C, Cifuentes C, Torrebadell-Burriel M, Isola I, Camós-Guijosa M, Ramírez M, Alarcón B and Toribio ML.

    Pre-TCR-targeted immunotherapy for T cell acute lymphoblastic leukemia

    NATURE IMMUNOLOGY . 26(10): 1712-1725. Nº de citas: 3

    [doi:10.1038/s41590-025-02265-w]

  • Iriondo J, Zubicaray J, Río P, Català-Temprano A, Solsona M, Sanz A, Gómez A, Sebastián E, de la Cruz A, Galán A, Navarro S, Larcher L, de Andoin NG, Uriz JJ, Vagace JM, Gonzalez de Pablo J, Pujol MR, Nicoletti E, Surrallés J, Martín-Prado S, Schwartz JD, Soulier J, Bueren JA and Sevilla J.

    Eltrombopag for Bone Marrow Failure in Fanconi Anemia: Results From the Phase II Clinical Trial FANCREV

    EUROPEAN JOURNAL OF HAEMATOLOGY . 115(4): 403-412.

    [doi:10.1111/ejh.70007]

  • Bartoló-Ibars A, Aran A, Johansson AM, Ortiz-Maldonado V, Klein-González N, Alonso-Saladrigues A, James E, Urbano-Ispizua A, Rives-Solà S, Delgado J, González-Navarro EA, Kwok WW and Juan-Otero M.

    T-cell responses against CD19-targeted CAR T cells varnimcabtagene autoleucel (ARI-0001): implications for immune response and therapy outcomes

    Journal for ImmunoTherapy of Cancer . 13(9): .

    [doi:10.1136/jitc-2024-010792]

  • Awasthi R, Grupp SA, Waldron E, Yanik GA, Tam CS, Rives-Solà S, McGuirk JP, Pulsipher MA, Jaeger U, Myers GD, Borchmann P, Schuster SJ, Stefanski HE, Bishop MR, Chakraborty A, Masood A, Baruchel A and Waller EK.

    Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL

    Blood Advances . 9(17): 4405-4414.

    [doi:10.1182/bloodadvances.2024014995]

  • Silbert SK, Rankin AW, Hoang CN, Semchenkova A, Myers RM, Zerkalenkova E PhD, Wang HW, Kovach AE, Yuan CM, Delgado Colon D, Vasseur L, Bataller A, John S, Utley Lyons K, Friedes BD, Alonso-Saladrigues A, Abdel-Azim H, Balducci E, Aljudi A, Balsat M, Biery DN, Chamdin A, Chang BH, Cuevo RS MD, De Moerloose B, Dickens DS, Duffner UA, Duployez N, El Chaer F, Elliott MA, Escherich G, Fernandes S, Fitzjohn MR, Gahvari ZJ, Grupp SA, He RR MD, Harrison C, Hergott CB, Hsieh EM, Kim AS, Kuo DJ, Larson DP, Lee BJ, Leguay TT, Lindsley RC, Mangaonkar AA, Mezger K, Pacenta HL, Pan J, Provost MRM, Puri L, Raikar SS, Martinez AJ, Bristol IQ, Murphy KD, Reiman L, Redell MS, Reed K, Roth Guepin G, Rubinstein JD, Savasan S, Schafernak KT, McLean Stevens A, Talleur AC, Torres Carapia N, Vargaftig J, Vatsayan A, Wölfl M, Zhao L, Rives-Solà S, Fabrizio VA, Sasaki K, Aldoss I, Boissel N, Rheingold SR, Davis KL, Ghorashian S, Jacoby E, Popov A, Lamble AJ and Shah NN.

    Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

    BLOOD . 146(4): 437-455. Nº de citas: 13

    [doi:10.1182/blood.2024026655]

  • Kotmayer L, Kozyra EJ, Kang G, Strahm B, Yoshimi A, Sahoo SS, Pastor VB, Attardi E, Voss R, Vinci L, Kaiser M, Dworzak MN, De Moerloose B, Sukova M, Starý J, Hasle H, Jahnukainen K, Polychronopoulou S, Kállay K, Smith OP, Malone A, Barzilai Birenboim S, Masetti R, Buechner J, Ussowicz M, Kjöllerström P, Bodova I, Kavcic M, Català-Temprano A, Turkiewicz D, Schmugge M, de Haas V, Okhomina VI, Sotomayor C, Catalán P, Wehr C, Salzer U, Germing U, Gattermann N, Bödör C, Gray N, Lewis S, Shimamura A, Giorgetti A, Erlacher M, Niemeyer CM and Wlodarski MW.

    Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency

    Blood Cancer Journal . 15(1): 121-121. Nº de citas: 6

    [doi:10.1038/s41408-025-01309-6]

  • CastilloSD, Perosanz X, Ressler AK, Ivars M, Rodriguez J, Rovira-Zurriaga C, Nola EM, Llena J, Grego-Bessa J, Roldan-Molina M, Arnau R, Martínez-Romero A, Barber-Martínez de la Torre I, Miguel Bejarano Serrano, Vicente-Villa MA, Celis-Passini V, Salvador-Hernandez H, Mora J, Marchuk DA, Baselga E and Graupera M.

    Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome

    Cancer Discovery . 15(7): 1350-1362. Nº de citas: 8

    [doi:10.1158/2159-8290.CD-24-0807]

  • Tirado N, Fidyt K, Mansilla MJ, Garcia-Perez A, Martínez-Moreno A, Vinyoles M, Alcain J, García-Peydró M, Roca-Ho H, Fernandez-Fuentes N, Guerrero-Murillo M, Falgàs A, Velasco-Hernandez T, Bueno C, Panelli P, Mulens-Arias V, Apostolov A, Engel P, González EA, Vick B, Jeremias I, Caye-Eude A, Baruchel A, Cavé H, Genescà E, Ribera J, Díaz-Beyá M, Martínez-Sánchez MV, Fuster JL, Escudero López A, Minguillón J, Pérez-Martínez A, Ramírez-Orellana M, Torrebadell-Burriel M, Díaz VM, Toribio ML, Sánchez-Martínez D and Menéndez P.

    CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia

    Journal of Hematology & Oncology . 18(1): 69-69. Nº de citas: 7

    [doi:10.1186/s13045-025-01715-0]